Seres Therapeutics
MCRB
MCRB
85 hedge funds and large institutions have $326M invested in Seres Therapeutics in 2017 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 25 increasing their positions, 24 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
85
Holders Change
+5
Holders Change %
+6.25%
% of All Funds
1.93%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
17
Increased
25
Reduced
24
Closed
12
Calls
$1.07M
Puts
$698K
Net Calls
+$371K
Net Calls Change
+$7.41M
Top Buyers
| 1 |
AIM
1
ARK Investment Management
St. Petersburg,
Florida
|
$16.5M |
| 2 |
2
Federated Hermes
Pittsburgh,
Pennsylvania
|
$15.2M |
| 3 |
3
Renaissance Technologies
New York
|
$9.24M |
| 4 |
4
Jennison Associates
New York
|
$2.31M |
| 5 |
5
JPMorgan Chase & Co
New York
|
$5.35M |
Top Sellers
| 1 |
1
Capital World Investors
Los Angeles,
California
|
$10.5M |
| 2 |
2
T. Rowe Price Associates
Baltimore,
Maryland
|
$1.05M |
| 3 |
AG
3
Artal Group
Luxembourg
|
$3.04M |
| 4 |
PA
4
Perceptive Advisors
New York
|
$0 |
| 5 |
5
D.E. Shaw & Co
New York
|
$3.86M |
